Please use this identifier to cite or link to this item: http://hdl.handle.net/11189/4475
DC FieldValueLanguage
dc.contributor.authorDave, Joel Alex Lex-
dc.contributor.authorLambert, Estelle V-
dc.contributor.authorBadri, Motasim A.-
dc.contributor.authorMaartens, Gary-
dc.contributor.authorLevitt, Naomi Sharlene-
dc.contributor.authorWest, Sacha Jane-
dc.date.accessioned2016-06-29T08:39:42Z-
dc.date.available2016-06-29T08:39:42Z-
dc.date.issued2011-
dc.identifier.urihttp://hdl.handle.net/11189/4475-
dc.description.abstractBackground: Data on the prevalence of the complications of antiretroviral therapy (ART) (diabetes, central fat accumulation, peripheral fat wasting, and dyslipidemia) in sub-Saharan Africa are sparse. We examined the prevalence and associated risk factors of dysglycemia and insulin sensitivity in HIV-infected South Africans. Methods: HIV-infected patients, on nonnucleoside reverse transcriptase inhibitor-based ART or ART-naive, had oral glucose tolerance tests and clinical anthropometry. Insulin sensitivity and β-cell function were assessed. Results: The prevalence of dysglycemia in 406 ART-naive patients and 443 patients on ART was 25.7% and 21.9% (P = 0.193), respectively. Dysglycemic patients on ART had a similar body mass index (P = 0.440), greater waist circumference (P = 0.047), and smaller calf skinfold thickness (P = 0.015) than dysglycemic ART-naive patients but no difference in β-cell function or insulin sensitivity. Normoglycemic patients on ART had a greater body mass index (P = 0.0009), waist circumference (P = 0.0001), and abdominal skinfold thickness (P = 0.040), similar calf skinfold thickness (P = 0.079), and reduced β-cell function [lower insulinogenic index (P = 0.027) and oral disposition index (Do, P = 0.020)] compared with normoglycemic ART-naive patients. In multivariate analysis, older age [odds ratio (OR): 1.04, 95% confidence interval (CI): 1.02 to 1.06], male gender (OR: 1.96, 95% CI: 1.28 to 2.99), higher CD4 count (OR: 1.0, 95% CI: 1.00 to 1.02) and use of efavirenz (OR: 1.70, 95% CI: 1.19 to 2.45) were associated with dysglycemia.en_US
dc.language.isoenen_US
dc.publisherJournal of Acquired Immune Deficiency Syndromesen_US
dc.rights.urihttp://creativecommons.org/licenses/by-nc-sa/3.0/za/en
dc.subjectAntiretroviral therapyen_US
dc.subjectDiabetesen_US
dc.subjectDysglycemiaen_US
dc.subjectHuman Immunodeficiency Virus (HIV)en_US
dc.subjectImpaired glucose metabolismen_US
dc.titleEffect of nonnucleoside reverse transcriptase inhibitor-based antiretroviral therapy on dysglycemia and insulin sensitivity in South African HIV-Infected Patientsen_US
dc.type.patentArticleen_US
Appears in Collections:BUS - Journal Articles (DHET subsidised)
Show simple item record

Page view(s)

20
Last Week
0
Last month
1
checked on Jun 25, 2019

Download(s)

11
checked on Jun 25, 2019

Google ScholarTM

Check


This item is licensed under a Creative Commons License Creative Commons